Chutes & Ladders: Wheeler tapped to run Momenta
Momenta Pharmaceuticals has tapped Craig Wheeler, the former president of Chiron BioPharmaceuticals, to be its next CEO. Alan Crane, who's stepping down from the post, will stay on the board.
- here's the report on Wheeler from the Boston Globe
ALSO: Fresh from raising $60 million in new venture funds, Prestwick Pharmaceuticals has named George F. Horner III president and CEO. Release
PLUS: Howard D. Goldstein has accepted the top position at Arcxis Biotechnologies, signaling the company's move into commercial development of its technologies for rapid, diagnostic gene and protein identification. Release
Comments